• 7034 Citations
  • 36 h-Index
1987 …2024
If you made any changes in Pure these will be visible here soon.

Research Outputs 1987 2019

Filter
Article
2019

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Rini, B. I., Powles, T., Atkins, M. B., Escudier, B., McDermott, D. F., Suarez, C., Bracarda, S., Stadler, W. M., Donskov, F., Lee, J. L., Hawkins, R., Ravaud, A., Alekseev, B., Staehler, M., Uemura, M., De Giorgi, U., Mellado, B., Porta, C., Melichar, B., Gurney, H. & 12 othersBedke, J., Choueiri, T. K., Parnis, F., Khaznadar, T., Thobhani, A., Li, S., Piault-Louis, E., Frantz, G., Huseni, M., Schiff, C., Green, M. C. & Motzer, R. J., 15 Jun 2019, In : The Lancet. 393, 10189, p. 2404-2415 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Randomized Controlled Trials
Disease-Free Survival
Ligands
Research Personnel

Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma

Motzer, R. J., Penkov, K., Haanen, J., Rini, B., Albiges, L., Campbell, M. T., Venugopal, B., Kollmannsberger, C., Negrier, S., Uemura, M., Lee, J. L., Vasiliev, A., Miller, W. H., Gurney, H., Schmidinger, M., Larkin, J., Atkins, M. B., Bedke, J., Alekseev, B., Wang, J. & 8 othersMariani, M., Robbins, P. B., Chudnovsky, A., Fowst, C., Hariharan, S., Huang, B., Di Pietro, A. & Choueiri, T. K., 21 Mar 2019, In : New England Journal of Medicine. 380, 12, p. 1103-1115 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Disease-Free Survival
sunitinib
avelumab
axitinib
Plasmas
Monitoring
Neoplasms
Drug Monitoring
Castration

Continuing cabazitaxel beyond 10 cycles for metastatic castrate-resistant prostate cancer: is there a benefit?

Al-Mansouri, L., Arasaratnam, M. & Gurney, H., 14 Jun 2019, In : European Journal of Hospital Pharmacy.

Research output: Contribution to journalArticleResearchpeer-review

Prostatic Neoplasms
Survival
Prostate-Specific Antigen
Castration
Alkaline Phosphatase

Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer

Arasaratnam, M., Crumbaker, M., Bhatnagar, A., McKay, M. J., Molloy, M. P. & Gurney, H., Jul 2019, In : Cancer Chemotherapy and Pharmacology. 84, 1, p. 139-146 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Pharmacokinetics
Prostatic Neoplasms
Pharmaceutical Preparations
Chemotherapy
Drug Therapy

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

Fradet, Y., Bellmunt, J., Vaughn, D. J., Lee, J. L., Fong, L., Vogelzang, N. J., Climent, M. A., Petrylak, D. P., Choueiri, T. K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D. I., Culine, S., Sternberg, C. N., Nam, K., Frenkl, T. L., Perini, R. F., De Wit, R. & Bajorin, D. F., 1 Jun 2019, In : Annals of Oncology. 30, 6, p. 970-976 7 p., mdz127.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
docetaxel
Paclitaxel
Drug Therapy
Neoplasms
Platinum

Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?

Lee, C. I., Fox, P., Balakrishnar, B., Balleine, R. L., Gao, B., Provan, P., Coulter, S., Liddle, C., Hui, R., Wong, M., Gurney, H. & Wilcken, N., 1 Aug 2019, In : Breast. 46, p. 52-57 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Hot Flashes
Tamoxifen
Cytochrome P-450 CYP2D6
4-hydroxy-N-desmethyltamoxifen
Compliance
2018

Abiraterone alone or in combination with enzalutamide in metastatic castration-resistant prostate cancer with rising prostate-specific antigen during enzalutamide treatment

Attard, G., Borre, M., Gurney, H., Loriot, Y., Andresen-Daniil, C., Kalleda, R., Pham, T., Taplin, M. E. & on behalf of PLATO collaborators, 1 Sep 2018, In : Journal of Clinical Oncology. 36, 25, p. 2639-2646 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Castration
Prostate-Specific Antigen
Prostatic Neoplasms
Prednisone
Control Groups

Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews

Van Leeuwen, M. T., Luu, S., Gurney, H., Brown, M. R., Webber, K., Pearson, S-A., Hunt, L. & Vajdic, C. M., 1 Jun 2018, In : BMJ Open. 8, 6, p. 1-6 6 p., e021064.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Ethics
Embolism and Thrombosis
Cerebrovascular Disorders
Neoplasms
Peer Review

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

Gao, B., Lu, Y., Nieuweboer, A. J. M., Xu, H., Beesley, J., Boere, I., De Graan, A. J. M., De Bruijn, P., Gurney, H., Kennedy, C. J., Chiew, Y. E., Johnatty, S. E., Beale, P., Harrison, M., Luccarini, C., Conroy, D., Mathijssen, R. H. J., Harnett, P. R., Balleine, R. L., Chenevix-Trench, G. & 2 othersMacGregor, S. & De Fazio, A., 1 Dec 2018, In : Scientific Reports. 8, 1, p. 1-10 10 p., 1508.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Genome-Wide Association Study
Carboplatin
Paclitaxel
Single Nucleotide Polymorphism
Drug Therapy

Health-related quality-of-life analysis from KEYNOTE-045: a phase III study of pembrolizumab versus chemotherapy for previously treated advanced urothelial cancer

Vaughn, D. J., Bellmunt, J., Fradet, Y., Lee, J. L., Fong, L., Vogelzang, N. J., Climent, M. A., Petrylak, D. P., Choueiri, T. K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D. I., Culine, S., Sternberg, C. N., Mai, Y., Li, H., Perini, R. F., Bajorin, D. F. & de Wit, R., 1 Jun 2018, In : Journal of Clinical Oncology. 36, 16, p. 1579-1587 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Quality of Life
Drug Therapy
Neoplasms
Health Status
Research Personnel

Nivolumab in the treatment of advanced renal cell carcinoma

Arasaratnam, M. & Gurney, H., Jul 2018, In : Future Oncology. 14, 17, p. 1679-1689 11 p., 29460635.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Neoplasms
Interleukin-2
Therapeutics
Biomarkers

Nivolumab plus Ipilimumab versus Sunitinib in advanced renal-cell carcinoma

Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., Powles, T., Donskov, F., Neiman, V., Kollmannsberger, C. K., Salman, P., Gurney, H., Hawkins, R., Ravaud, A., Grimm, M. O., Bracarda, S. & 13 othersBarrios, C. H., Tomita, Y., Castellano, D., Rini, B. I., Chen, A. C., Mekan, S., McHenry, M. B., Wind-Rotolo, M., Doan, J., Sharma, P., Hammers, H. J., Escudier, B. & CheckMate 214 Investigators, 5 Apr 2018, In : New England Journal of Medicine. 378, 14, p. 1277-1290 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Disease-Free Survival
Survival
nivolumab
ipilimumab

Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma

Powles, T., Motzer, R. J., Escudier, B., Pal, S., Kollmannsberger, C., Pikiel, J., Gurney, H., Rha, S. Y., Park, S. H., Geertsen, P. F., Gross-Goupil, M., Grande, E., Suarez, C., Markby, D. W., Arroyo, A., Dean, M., Choueiri, T. K. & George, D., 11 Sep 2018, In : British Journal of Cancer. 119, 6, p. 663-669 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Renal Cell Carcinoma
Disease-Free Survival
Survival
Therapeutics
Everolimus
Plasma (human)
Metabolites
Mass spectrometry
Mass Spectrometry
Pharmaceutical Preparations

Real-world experience of the feasibility and tolerability of the 2/1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia

Crumbaker, M., Guminski, A., Gurney, H., Sabanathan, D., Wong, S. & Pavlakis, N., Apr 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, 2, p. e45-e49 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Appointments and Schedules
Therapeutics
sunitinib
Survival
2017

A Distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer

PRIMe Consortium, 15 Nov 2017, In : International Journal of Cancer. 141, 10, p. 2112-2120 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Castration
Prostatic Neoplasms
Lipids
Sphingolipids
Survival

Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program

Parente, P., Ng, S., Parnis, F., Guminski, A. & Gurney, H., Dec 2017, In : Asia-Pacific Journal of Clinical Oncology. 13, 6, p. 391-399 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Castration
Prostatic Neoplasms
Quality of Life
Safety
docetaxel

CheckMate 025 randomized Phase 3 study: outcomes by key baseline factors and prior therapy for nivolumab versus everolimus in advanced renal cell carcinoma

Escudier, B., Sharma, P., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Gurney, H., Donskov, F., Peltola, K., Wagstaff, J., Gauler, T. C., Ueda, T., Zhao, H., Waxman, I. M., Motzer, R. J. & 1 others CheckMate 025 Investigators, 2017, In : European Urology. 72, 6, p. 962-971 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Outcome Assessment (Health Care)
Survival
Therapeutics
Standard of Care

Communicating risk in active surveillance of localised prostate cancer: A protocol for a qualitative study

Rapport, F., Hogden, A., Gurney, H., Gillatt, D., Bierbaum, M., Shih, P. & Churruca, K., 1 Oct 2017, In : BMJ Open. 7, 10, p. 1-7 7 p., e017372.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Prostatic Neoplasms
Referral and Consultation
Health
Interviews
Communication

Cure in advanced renal cell cancer: Is it an achievable goal?

Sabanathan, D., Park, J. J., Marquez, M., Francisco, L., Byrne, N. & Gurney, H., 1 Dec 2017, In : Oncologist. 22, 12, p. 1470-1477 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Death Domain Receptors
Immunotherapy
Therapeutics
Radiotherapy

Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival

Patel, M. I., Beattie, K., Bang, A., Gurney, H. & Smith, D. P., Oct 2017, In : Cancer Medicine. 6, 10, p. 2188–2193 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Nephrectomy
Renal Cell Carcinoma
Survival
Insurance
South Australia

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring

Sabanathan, D., Zhang, A., Fox, P., Coulter, S., Gebski, V., Balakrishnar, B., Chan, M., Liddle, C. & Gurney, H., Aug 2017, In : Cancer Chemotherapy and Pharmacology. 80, 2, p. 385–393 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Drug Monitoring
Renal Cell Carcinoma
Toxicity
Monitoring
Pharmaceutical Preparations

e-TC: development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer

Heiniger, L. E., Smith, A. B., Olver, I., Grimison, P., Klein, B., Wootten, A., Abbott, J-A. M., Price, M. A., McJannett, M., Tran, B., Stockler, M. R., Gurney, H. & Butow, P. N., Nov 2017, In : European journal of cancer care. 26, 6, p. 1-10 10 p., e12698.

Research output: Contribution to journalArticleResearchpeer-review

Testicular Neoplasms
Survivors
Anxiety
Depression
Psychology

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: a Renal Cross Channel Group study

Colomba, E., Le Teuff, G., Eisen, T., Stewart, G. D., Fife, K., Larkin, J., Biondo, A., Pickering, L., Srinivasan, A., Boyle, H., Derosa, L., Sternberg, C. N., Recine, F., Ralph, C., Saldana, C., Barthélémy, P., Bernhard, J. C., Gurney, H., Verhoest, G., Vauleon, E. & 11 othersBigot, P., Berger, J., Pfister, C., Gravis, G., Rodier, J-M., Culine, S., Caty, A., Rolland, F., Priou, F., Escudier, B. & Albiges, L., 1 Jul 2017, In : European Journal of Cancer. 80, p. 55-62 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Sirolimus
Renal Cell Carcinoma
Treatment Failure
Kidney
Confidence Intervals

Pembrolizumab as second-line therapy for advanced urothelial carcinoma

Bellmunt, J., de Wit, R., Vaughn, D. J., Fradet, Y., Lee, J-L., Fong, L., Vogelzang, N. J., Climent, M. A., Petrylak, D. P., Choueiri, T. K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D. I., Culine, S., Sternberg, C. N., Mai, Y., Poehlein, C. H., Perini, R. F. & Bajorin, D. F., 16 Mar 2017, In : New England Journal of Medicine. 376, 11, p. 1015-1026 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Confidence Intervals
Carcinoma
Drug Therapy
Platinum
Neoplasms

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

Lin, H-M., Mahon, K. L., Spielman, C., Gurney, H., Mallesara, G., Stockler, M. R., Bastick, P., Briscoe, K., Marx, G., Swarbrick, A. & Horvath, L. G., 11 Apr 2017, In : British Journal of Cancer. 116, 8, p. 1002-1011 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Castration
MicroRNAs
docetaxel
Prostatic Neoplasms
Biomarkers

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

Hopkins, A. M., Rowland, A., Kichenadasse, G., Wiese, M. D., Gurney, H., McKinnon, R. A., Karapetis, C. S. & Sorich, M. J., 26 Sep 2017, In : British Journal of Cancer. 117, 7, p. 913-920 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Biomarkers
Therapeutics
Leukocyte Count
Research
C-Reactive Protein

Treatment beyond progression in patients with advanced renal cell carcinoma treated with nivolumab in CheckMate 025

Escudier, B., Motzer, R. J., Sharma, P., Wagstaff, J., Plimack, E. R., Hammers, H. J., Donskov, F., Gurney, H., Sosman, J. A., Zalewski, P. G., Harmenberg, U., McDermott, D. F., Choueiri, T. K., Richardet, M., Tomita, Y., Ravaud, A., Doan, J., Zhao, H., Hardy, H. & George, S., Sep 2017, In : European Urology. 72, 3, p. 368-376 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Therapeutics
Karnofsky Performance Status
Response Evaluation Criteria in Solid Tumors
nivolumab
2016

Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study

Fox, P., Balleine, R. L., Lee, C., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wong, M., Wilcken, N. & Gurney, H., 1 Jul 2016, In : Clinical Cancer Research. 22, 13, p. 3164-3171 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Drug Monitoring
Tamoxifen
Hot Flashes
Cytochrome P-450 CYP2D6
Genotype

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

Nath, C. E., Trotman, J., Tiley, C., Presgrave, P., Joshua, D., Kerridge, I., Kwan, Y. L., Gurney, H., McLachlan, A. J., Earl, J. W., Nivison-Smith, I., Zeng, L. & Shaw, P. J., Jul 2016, In : British Journal of Clinical Pharmacology. 82, 1, p. 149-159 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Melphalan
Autologous Transplantation
Area Under Curve
Survival
Stem Cell Transplantation

Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011

van Leeuwen, M. T., Gurney, H., Turner, J. J., Turner, S. L., Pearson, S. A., Laaksonen, M. A., Harnett, P., Balakrishnar, B., Sabanathan, D. & Vajdic, C. M., 1 Aug 2016, In : Cancer Epidemiology. 43, p. 15-21 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Germ Cell and Embryonal Neoplasms
Pediatrics
Incidence
Neoplasms
Germinoma

Tactic: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer

Ferraro, D., Goldstein, D., O’Connell, R. L., Zalcberg, J. R., Sjoquist, K. M., Tebbutt, N. C., Grimison, P., McLachlan, S., Lipton, L. L., Vasey, P., Gebski, V. J., Aiken, C., Cronk, M., Ng, S., Karapetis, C. S., Shannon, J., Shannon, J., Tebbutt, N., Ng, S., Cronk, M. & 48 othersKarapetis, C., Sjoquist, K., Aiken, C., Do, V., Marschner, I., Friedlander, M., Gurney, H., Simes, J., Hague, W., O’Connell, R., Gebski, V., Aiken, C., Gorzeman, M., Pike, R., Miranda, K., Waring, P., Ferraro, D., Lau, D., Fox, S., Tebbutt, N., Liu, Y., Vasey, P., Wood, T., Cronk, M., Cocks, C., Simmons, K., Shannon, J., McCourt, J., Jefford, M., Hobinchet, A., Grimison, P., Mirco, B., Sagong, J., Ng, S., Dudukovic, S., Aghmesheh, M., Parker, S., Segelov, E., Ratnayake, L., McLachlan, S., Ranieri, N., Varma, S., Page, J., Heyer, E., Abdi, E., Chorlton, C., Lipton, L. & Wilkinson, L., 1 Aug 2016, In : Cancer Chemotherapy and Pharmacology. 78, 2, p. 361-367 7 p.

Research output: Contribution to journalArticleResearchpeer-review

gemcitabine
Biliary Tract Neoplasms
Cisplatin
Toxicity
Labels

Tamoxifen, CYP2D6 and endoxifen in the treatment of hormone sensitive breast cancer: demystifying the connections

Lee, C. I. & Gurney, H., 1 Nov 2016, In : Cancer Forum. 40, 3, p. 4-10 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytochrome P-450 CYP2D6
Tamoxifen
Hormones
Breast Neoplasms
Selective Estrogen Receptor Modulators

The effect of pulmonary function testing on bleomycin dosing in germ cell tumours

Roncolato, F. T., Chatfield, M., Houghton, B., Toner, G., Stockler, M., Thomson, D., Friedlander, M., Gurney, H., Rosenthal, M., Grimison, P. & The Australian and New Zealand Urogenital Prostate Cancer Trials Group (ANZUP), 1 Aug 2016, In : Internal Medicine Journal. 46, 8, p. 893-898 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Germ Cell and Embryonal Neoplasms
Bleomycin
Lung
Vital Capacity
Lung Volume Measurements

The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study

Smith, A. B., Butow, P., Olver, I., Luckett, T., Grimison, P., Toner, G. C., Stockler, M. R., Hovey, E., Stubbs, J., Turner, S., Hruby, G., Gurney, H., Alam, M., Cox, K. & King, M. T., 1 Apr 2016, In : Journal of Cancer Survivorship. 10, 2, p. 223-233 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Testicular Neoplasms
Survival Rate
Quality of Life
Psychology
Survivors
2015

Describing patterns of care in pancreatic cancer a population-based study: a population-based study

Burmeister, E. A., OʼConnell, D. L., Beesley, V. L., Goldstein, D., Gooden, H. M., Janda, M., Jordan, S. J., Merrett, N. D., Payne, M. E., Wyld, D. K., Neale, R. E. & Pancreatic Cancer Patterns of Care Study Group, Nov 2015, In : Pancreas. 44, 8, p. 1259-65 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Pancreatic Neoplasms
Population
Adjuvant Chemotherapy
Neoplasms
Medical Records

Doctor-patient communication: a study of Australian ethnic urological cancer patients

Cerimagic, S., Ahmadi, N., Gurney, H. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 82-91 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Urologic Neoplasms
cancer
Communication
communication
illness

Nivolumab versus everolimus in advanced renal-cell carcinoma

Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Choueiri, T. K., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Tomita, Y., Schutz, F. A. & 8 othersKollmannsberger, C., Larkin, J., Ravaud, A., Simon, J. S., Xu, L. A., Waxman, I. M., Sharma, P. & CheckMate 025 Investigators, 5 Nov 2015, In : New England Journal of Medicine. 373, 19, p. 1803-1813 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Renal Cell Carcinoma
Confidence Intervals
Survival
Everolimus
nivolumab

Positive lifestyle changes following urological cancer diagnoses: an Australian interview based study

Cerimagic, S., Ahmadi, N., Gurney, H., Hossack, T. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 110-119 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Urologic Neoplasms
Life Style
cancer
Interviews
interview
2014

Accelerated BEP for metastatic germ cell tumours: A multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Grimison, P. S., Stockler, M. R., Chatfield, M., Thomson, D. B., Gebski, V., Friedlander, M., Boland, A. L., Houghton, B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. & Toner, G. C., 2014, In : Annals of Oncology. 25, 1, p. 143-148 6 p., mdt369.

Research output: Contribution to journalArticleResearchpeer-review

Urogenital Neoplasms
Germ Cell and Embryonal Neoplasms
Bleomycin
Etoposide
New Zealand

Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662

Diekstra, M. H. M., Klümpen, H. J., Lolkema, M. P. J. K., Yu, H., Kloth, J. S. L., Gelderblom, H., Van Schaik, R. H. N., Gurney, H., Swen, J. J., Huitema, A. D. R., Steeghs, N. & Mathijssen, R. H. J., 2014, In : Clinical Pharmacology and Therapeutics. 96, 1, p. 81-89 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Genetic Polymorphisms
Pharmacokinetics
Single Nucleotide Polymorphism
Cytochrome P-450 CYP3A
Genes

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

Lin, H. M., Castillo, L., Mahon, K. L., Chiam, K., Lee, B. Y., Nguyen, Q., Boyer, M. J., Stockler, M. R., Pavlakis, N., Marx, G., Mallesara, G., Gurney, H., Clark, S. J., Swarbrick, A., Daly, R. J. & Horvath, L. G., 13 May 2014, In : British Journal of Cancer. 110, 10, p. 2462-2471 10 p.

Research output: Contribution to journalArticleResearchpeer-review

docetaxel
Castration
MicroRNAs
Prostatic Neoplasms
Drug Therapy

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

Mahon, K. L., Qu, W., Devaney, J., Paul, C., Castillo, L., Wykes, R. J., Chatfield, M. D., Boyer, M. J., Stockler, M. R., Marx, G., Gurney, H., Mallesara, G., Molloy, P. L., Horvath, L. G. & Clark, S. J., 28 Oct 2014, In : British Journal of Cancer. 111, 9, p. 1802-1809 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Glutathione Transferase
Genetic Markers
Epigenomics
Prostatic Neoplasms
Drug Therapy

Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: The ClearSun study

Kloth, J. S. L., Klümpen, H. J., Yu, H., Eechoute, K., Samer, C. F., Kam, B. L. R., Huitema, A. D. R., Daali, Y., Zwinderman, A. H., Balakrishnar, B., Bennink, R. J., Wong, M., Schellens, J. H. M., Mathijssen, R. H. J. & Gurney, H., Mar 2014, In : Clinical Pharmacokinetics. 53, 3, p. 261-269 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Cytochrome P-450 CYP3A
Pharmacokinetics
Midazolam
Phenotype
Nonlinear Dynamics
2013

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2

Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P. H., Wong, M., Gurney, H., Church, W. B. & Murray, M., 2013, In : AAPS Journal. 15, 4, p. 1099-1108 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Single Nucleotide Polymorphism
Biotinylation
Molecular Models
Membranes
HEK293 Cells

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H. & Donskov, F., 2013, In : Journal of Translational Medicine. 11, p. 189 1 p.

Research output: Contribution to journalArticleResearchpeer-review

Chemotherapy
Neutropenia
Non-Small Cell Lung Carcinoma
Ovarian Neoplasms
Neutrophils

Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer

Won, A. C. M., Gurney, H., Marx, G., De Souza, P. & Patel, M. I., Aug 2013, In : BJU international. 112, 4, p. E250-E255 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Prostate
Prostatic Neoplasms
Prostatectomy
Radiotherapy
Therapeutics

The prevalence and correlates of supportive care needs in testicular cancer survivors: A cross-sectional study

Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G. C., Stockler, M., Hovey, E., Stubbs, J., Hruby, G., Gurney, H., Turner, S., Alam, M., Cox, K. & Olver, I., Nov 2013, In : Psycho-Oncology. 22, 11, p. 2557-2564 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Testicular Neoplasms
Survivors
Cross-Sectional Studies
Psychology
Survival Rate